SEC 13F Intelligence

Natixis Advisors, LLC / ELV

Natixis Advisors, LLC’s Elevance Health Inc Formerly Position

Does Natixis Advisors, LLC own Elevance Health Inc Formerly (ELV)? Yes211.2K shares worth $62M (+0.09% of its 13F portfolio) as of Q1 2026, down from 267.1K shares the prior filed quarter.

Position Value
$62M
Q1 2026
Shares
211.2K
% of Portfolio
+0.09%
Quarters Held
30
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $27MQ4 ’18Q1 ’19: $28MQ2 ’19: $33MQ3 ’19: $23MQ4 ’19: $34MQ4 ’19Q1 ’20: $29MQ2 ’20: $37MQ3 ’20: $38MQ4 ’20: $47MQ4 ’20Q1 ’21: $54MQ2 ’21: $60MQ3 ’21: $59MQ4 ’21: $77MQ4 ’21Q1 ’22: $86MQ2 ’22: $85MQ3 ’22: $85MQ4 ’22: $86MQ4 ’22Q1 ’23: $75MQ2 ’23: $59MQ3 ’23: $62MQ4 ’23: $76MQ4 ’23Q1 ’24: $89MQ2 ’24: $96MQ3 ’24: $100MQ4 ’24: $46MQ4 ’24Q1 ’25: $72MQ2 ’25: $74MQ3 ’25: $79MQ4 ’25: $94MQ4 ’25Q1 ’26: $62Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026211.2K$62M+0.09%
Q4 2025267.1K$94M+0.13%
Q3 2025244.8K$79M+0.12%
Q2 2025190.1K$74M+0.12%
Q1 2025165.5K$72M+0.13%
Q4 2024123.4K$46M+0.09%
Q3 2024192.1K$100M+0.19%
Q2 2024177.6K$96M+0.21%
Q1 2024171.9K$89M+0.20%
Q4 2023160.7K$76M+0.20%
Q3 2023142.9K$62M+0.19%
Q2 2023131.9K$59M+0.18%
Q1 2023163.3K$75M+0.26%
Q4 2022167.2K$86M+0.32%
Q3 2022186.2K$85M+0.36%
Q2 2022177.1K$85M+0.38%
Q1 2022175.5K$86M+0.33%
Q4 2021166.1K$77M+0.29%
Q3 2021157.0K$59M+0.24%
Q2 2021157.7K$60M+0.28%
Q1 2021151.8K$54M+0.28%
Q4 2020147.2K$47M+0.27%
Q3 2020140.2K$38M+0.24%
Q2 2020139.6K$37M+0.24%
Q1 2020126.7K$29M+0.23%
Q4 2019111.9K$34M+0.24%
Q3 201997.2K$23M+0.19%
Q2 2019115.6K$33M+0.27%
Q1 201998.2K$28M+0.25%
Q4 2018103.9K$27M+0.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of ELV.